wellrank.ai
Natesto logo

Natesto

First cited by AI Jun 12, 2026
natesto.com

Surfaced organically in AI answers about trt and men's health. Not yet profiled.

AI Visibility

Visibility trend

TRT and men's health, daily share of AI answers mentioning Natesto, through Jun 13, 2026.

8.3%

Avg position when mentioned: 7.0

By engine

Where Natesto is strong, and where it is invisible.

  • ChatGPT
    33.3%

Mention sentiment

Tone of AI mentions across all tracked answers.

  • 0 positive mentions
  • 3 neutral
  • 0 mixed or cautious

Recent AI answers mentioning Natesto

ChatGPTJun 13, 2026, 11:03 UTC
What testosterone level is low enough to need treatment?

Short answer: most guidelines use a total testosterone cutoff of about 300 ng/dL (≈10.4 nmol/L). Treatment is usually considered only if you have consistent low measurements plus symptoms of testosterone deficiency. Details and what that means for you Typical adult male total testosterone reference is roughly 300–1,000 ng/dL (10.4–34.7 nmol/L), though lab ranges vary. The Endocrine Society and American Urology Association commonly use a threshold of ~300 ng/dL. If total testosterone is below ~300 ng/dL on at least two morning (7–10 a.m.) measurements and you have symptoms (low libido, erectile problems, low energy/mood, loss of muscle mass, increased body fat, anemia, decreased bone density), treatment may be appropriate. Very low values (for example <200 ng/dL) are much more likely to cause symptoms and to prompt treatment or urgent evaluation. Important caveats Measure testosterone in the morning, while fasting if possible, and repeat the test because illness, stress, some meds, and acute medical problems can transiently lower levels. If total testosterone is borderline (250–350 ng/dL) or if you have conditions that change SHBG (obesity, diabetes, liver disease, thyroid disease), free testosterone or calculated bioavailable testosterone should be checked — labs report different reference ranges, so compare to your lab’s normal values. You also need further testing to find the cause: LH/FSH (to distinguish primary vs secondary hypogonadism), prolactin, and sometimes iron studies, sleep apnea screen, and metabolic testing. When NOT to give therapy and other concerns Don’t start exogenous testosterone if you have suspected or active breast or prostate cancer. Other contraindications/precautions include very high hematocrit, uncontrolled heart failure, and some recent cardiovascular events — these need individualized discussion with a clinician. Exogenous testosterone suppresses sperm production and can cause infertility. If you want to preserve or build fertility, alternatives include clomiphene citrate (commonly used off‑label) or hCG — discuss with a specialist. Common treatment options (examples and why) Topical gels: AndroGel, Testim — steady daily dosing, easy to use, but risk of transfer to others. Transdermal patch: Androderm — steady delivery, once-daily patch. Intramuscular injections: testosterone cypionate/enantate (often dispensed as Depo-Testosterone or generic testosterone cypionate) — less expensive, given every 1–3 weeks; can cause peaks and troughs. Long‑acting injections (testosterone undecanoate: Aveed/Nebido) provide more stable levels but require specific administration. Nasal: Natesto — multiple daily doses, lower systemic exposure between doses for some people. Fertility-preserving therapies: clomiphene citrate (Clomid, off‑label in men) or hCG (Ovidrel or prescribed hCG products) to raise endogenous testosterone without suppressing spermatogenesis as much. Monitoring if you start therapy Regular follow‑up with serum testosterone (to target mid‑normal range), hematocrit (risk of polycythemia), PSA, lipids, liver tests as indicated, and assessment of symptoms. Next step See your primary care doctor, urologist, or endocrinologist. Ask for a morning total testosterone test (and repeat it if low), plus LH/FSH and prolactin if the result is low. If you want, tell me your lab number(s) and symptoms and I can help interpret them and outline likely next steps.

Mentioned in position 7 of 9

Read full answer with sources →
ChatGPTJun 12, 2026, 12:44 UTC
Can I stop TRT once I start or is it forever?

Short answer: Yes — you can stop testosterone replacement therapy (TRT). It is not necessarily forever. But what happens after you stop depends on why you needed TRT, how long and how much you’ve been using, and whether you care about fertility. What to expect if you stop Your testosterone levels fall back to whatever your body was producing (often within days–weeks). Symptoms (low energy, low libido, depressed mood, loss of muscle, etc.) usually return and can take weeks–months to stabilize. Fertility: exogenous testosterone suppresses LH/FSH and sperm production. Sperm counts commonly fall within months and can take 3–12+ months to recover (sometimes longer or incompletely) once you stop. Bone health and metabolism: long-term TRT helps maintain bone density; stopping long-term TRT can gradually reduce bone density — consider monitoring if you stop. Recovery of your own HPT axis: if you have primary testicular failure (e.g., Klinefelter’s, orchiectomy, chemo), your testes may not recover and TRT may be needed lifelong. If your hypogonadism is secondary (HPA/pituitary-related or medication-related), recovery is more likely, especially if TRT duration was short. Options and steps to take Talk with your prescriber (primary care, endocrinologist, or urologist) before stopping. They’ll review why you started TRT and plan safe discontinuation and follow‑up. If fertility is desired, don’t simply stop and hope for the best — ask about alternatives that preserve or restore sperm production, such as: hCG (human chorionic gonadotropin; e.g., Pregnyl, Novarel) to stimulate testosterone production while preserving spermatogenesis, Clomiphene citrate (Clomid) — a SERM that can raise endogenous testosterone and preserve fertility, Enclomiphene (Androxal in some places) — similar SERM option in selected patients. If you stop TRT, your clinician may monitor morning total testosterone, LH/FSH, estradiol, CBC (hematocrit), PSA (if appropriate), and consider a semen analysis if fertility is a concern. Typical check times: 4–8 weeks after stopping, then at 3–6 months depending on symptoms. Consider DEXA if bone health is a concern. If you have been on TRT long-term or high doses, recovery may be slower; some clinicians use a short course of hCG or clomiphene to speed recovery of the axis. Common TRT products (so you know what you were using) Injectable: testosterone cypionate (Depo-Testosterone) or enanthate (often generic). Topical gels/solutions: AndroGel, Testim, Axiron. Nasal: Natesto (short-acting nasal gel). Long-acting intramuscular: Aveed (requires clinic administration). Different formulations have different pharmacology and fertility impacts; discuss switching formulations only with your clinician. Who to see Endocrinologist or urologist with men’s health experience for complicated cases. Male infertility or reproductive endocrinology clinics if fertility is important. If you used a commercial telehealth TRT service (e.g., Hims, Roman, Ro), contact them to arrange a supervised discontinuation and follow-up, but consider getting an in-person specialty consult for fertility or complex recovery. Bottom line You can stop TRT, but do it with medical guidance. If your hypogonadism is permanent (primary testicular failure) you may need ongoing TRT; if it’s reversible or secondary, your body may recover but that can take months and is not guaranteed. If you want children, talk to your provider first — there are specific treatments (hCG, clomiphene) that better preserve or restore fertility than standard TRT. If you want, tell me why you started TRT (reason, how long you’ve been on it, type/dose, whether you want children) and I can give more tailored guidance on what to expect and next steps.

Mentioned in position 9 of 13

Read full answer with sources →
ChatGPTJun 12, 2026, 12:43 UTC
How quickly does TRT work for energy and libido?

Short answer Libido: many men notice improvement within 1–3 weeks; most see meaningful benefit by 4–6 weeks. Energy/motivation/fatigue: usually takes longer — often 3–12 weeks, with the best gains by 3 months. Expect a full trial of TRT (dose/formulation optimized) of roughly 3–6 months before deciding whether it’s working for you. What affects how fast you’ll feel better Baseline testosterone level and how low you were. Lower starting T often gives faster/larger symptomatic change. Cause of symptoms (primary hypogonadism vs functional/age-related vs other medical/psychiatric causes). Formulation: injections and nasal products often produce quicker symptom changes than gels, patches, or pellets. Short-acting injections (testosterone cypionate/enanthate — e.g., Depo-Testosterone) or nasal gel (Natesto) can lead to mood/libido changes within days–weeks. Topical gels (AndroGel, Testim, Fortesta, Axiron) typically show effects over 2–6 weeks. Pellets (Testopel) and long‑acting depot injections (Aveed/Nebido) can take longer to reach steady state (weeks to months). Age, other health issues (sleep apnea, depression, thyroid disease, anemia), medications, and lifestyle (sleep, alcohol, obesity). What to expect clinically and on follow-up Timeline: libido first (1–6 weeks), energy/mood next (several weeks to months), muscle mass/strength 3–6 months, bone density many months to a year. Monitoring: your clinician should check morning total testosterone, hematocrit/hemoglobin, PSA (if appropriate), and repeat levels 2–12 weeks after starting or changing dose, then every 3–6 months initially. Safety/other considerations: TRT can raise hematocrit, affect fertility (suppresses sperm), and has prostate considerations. If you want future fertility, discuss alternatives (hCG, clomiphene) before starting TRT. Brands/services (examples) Gels/patches: AndroGel, Testim, Fortesta, Androderm — convenient topical options. Injections: Depo-Testosterone (testosterone cypionate), Aveed (long‑acting undecanoate) — injections often give faster symptom relief. Nasal: Natesto — faster onset and easier dose titration for some men. Pellets: Testopel — long‑lasting but slower to equilibrate. Telemedicine services (Hims, Roman) can be convenient for prescriptions and routine follow-up, but see an endocrinologist or urologist if you have complex issues, fertility concerns, or abnormal labs. When to reassess If you don’t notice improved libido or energy after 3 months at an adequate dose, follow up for dose adjustment, check labs (including free T, SHBG), and evaluate other causes (sleep, mood disorders, meds). If you want, tell me your age, whether you have recent morning testosterone levels, any medical conditions (sleep apnea, depression, desire for fertility), and which formulation you’re considering — I can give more tailored expectations and monitoring steps.

Mentioned in position 2 of 11

Read full answer with sources →

Public AI visibility history

Daily rank of Natesto on our buyer intent questions, per category. A dash means the engines did not cite Natesto at all that day. This record is permanent.

CategoryJun 11Jun 12Jun 13
TRT and men's health#36#31

TL;DR

Natesto is a prescription nasal testosterone gel developed by Acerus Pharmaceuticals and marketed in the United States for men with hypogonadism (low testosterone). It delivers testosterone through the nasal mucosa rather than through skin patches or injections, positioning it as a distinctive option within testosterone replacement therapy. According to WellRank's latest index, Natesto currently ranks tenth in AI-generated answers about TRT and men's health, capturing 8% visibility, with all three tracked AI mentions carrying a neutral tone.

Company Overview

Natesto is a branded prescription product originally developed by Acerus Pharmaceuticals, a Canadian specialty pharmaceutical company. In the United States it has been commercialized under licensing arrangements, and it is regulated and distributed as a Schedule III controlled substance consistent with other testosterone therapies. The business model is a traditional prescription pharmaceutical one, relying on physician prescribing, specialty pharmacy dispensing, and patient support programs.

Product Features

  • Nasal testosterone gel delivered via a metered-dose pump applied inside each nostril
  • Thrice-daily dosing regimen intended to mimic a more physiological testosterone rhythm
  • Formulation designed to avoid transference risk associated with topical skin gels
  • Avoidance of injection-related administration, appealing to needle-averse patients
  • Studied for effects on spermatogenesis, which has drawn interest in men who wish to preserve fertility

Target Market

Natesto is indicated for adult men diagnosed with hypogonadism, a condition characterized by low endogenous testosterone production. It is approved and primarily available in the United States. Its nasal delivery and fertility-related study data make it relevant to men of reproductive age who are concerned about the impact of testosterone therapy on sperm production.

Buyer Personas

  • A man in his 30s or 40s with clinically confirmed low testosterone who wants effective TRT but is concerned about transferring a topical gel to a partner or child.
  • A younger male patient with hypogonadism who is interested in maintaining fertility and has been counseled on Natesto's studied spermatogenesis profile.
  • A needle-averse man who has researched injection-based therapies like Depo-Testosterone or Aveed and prefers a non-injectable alternative.
  • A men's health patient working with an endocrinologist or urologist who wants a differentiated delivery method after trying conventional topical gels such as AndroGel or Axiron.

Funding & Performance

Natesto is a commercial prescription product of Acerus Pharmaceuticals, a publicly traded company on the Toronto Stock Exchange. Specific revenue figures, U.S. sales volumes, and recent financial performance details for the Natesto product line are not publicly disclosed at a granular level.

Recent Developments

Acerus has pursued expanded awareness of Natesto's nasal delivery differentiator and its clinical data around intratesticular testosterone and sperm production, which has generated interest in urology and men's health specialty channels. The broader TRT market has grown substantially with the rise of telehealth-first men's health platforms, creating both competitive pressure and new prescribing pathways that could surface Natesto to wider audiences. No major recent product reformulations or new indications are widely reported at this time.

Competitive Landscape

Within AI-answer co-mentions tracked by WellRank, Natesto surfaces alongside a broad set of competitors spanning branded injectables, topical gels, and telehealth platforms. Direct therapeutic competitors include AndroGel and Axiron in the topical gel category, and Depo-Testosterone and Aveed among injectable options. Telehealth-native brands such as Hims and Roman represent a different competitive vector, offering physician-supervised TRT through digital-first subscription models that can prescribe any FDA-approved therapy. Clomid appearing in co-mentions reflects the fertility-adjacent conversations in which Natesto sometimes participates.

Natesto vs the brands AI recommends alongside it

The real competitive set in TRT and men's health: brands the engines name in the same answers, ranked on the latest day.

BrandRankAI visibility
Natesto logo
NatestoThis brand
#31
8.3%
AndroGel logo
AndroGel

3 shared answers

#21
8.3%
Aveed logo
Aveed

3 shared answers

#26
8.3%
Depo-Testosterone logo
Depo-Testosterone

3 shared answers

#25
8.3%
Testim logo
Testim

3 shared answers

#22
8.3%

Email me when overtakes Natesto

One email the day the ranks flip. Nothing else.

User Sentiment

According to WellRank's corpus of tracked AI mentions, all three instances in which Natesto appears carry a neutral tone, with no positive or cautious framings recorded. This suggests AI engines currently treat it as a factual reference point within TRT discussions rather than a recommended or flagged option. Broader patient forum sentiment tends to focus on the novelty of nasal delivery and questions about the thrice-daily dosing convenience compared with longer-acting alternatives, though the overall public discussion volume remains modest relative to leading brands.

Pricing

As a brand-name prescription controlled substance, Natesto's out-of-pocket cost varies considerably depending on insurance coverage, pharmacy, and any manufacturer savings programs. Exact retail or cash-pay prices are not published by the manufacturer in a stable, publicly accessible format, and patients are generally directed to check with their pharmacy and review available copay assistance options.

Sources cited around Natesto

The sites engines cite in answers mentioning this brand. Win these, win the answer.

    Track Natesto weekly

    One email a week: rank moves, new competitors, and the answers that changed. No noise.

    Work at Natesto? Get your AI Visibility Audit.

    See every buyer intent question your customers ask AI, which ones you are losing, who wins them instead, and the exact sources driving those answers. You will finally understand your buyer intent and what Propel would do to win it.